The Impact of GLP-1s Medications on Health Plans
Latest News
CMS’s CY 2025 Final Rule: A Quick Summary
CMS’s CY 2025 Rate Announcement: Key Takeaways
CMS’s Final CY 2025 Part D Redesign Program: The Big Five Takeaways
Webinar: Medicare Prescription Payment Plan (M3P) of the Inflation Reduction Act (IRA)
GAO Report on Rebates in Medicare Part D Program
The Inflation Reduction Act of 2022...Winter is Coming
It’s That Time Again: MTM Program Submission
Part D Benefit Administration Testing (BAT)
What is your Medication Therapy Management Program really doing for your members?
2023 MA and Part D Final Rate Announcement Includes 8.5% Revenue Boost, Increased Star Ratings
Have you Implemented and Tested the 2022 Audit Protocols?
Rethinking Formularies
Rebellis Group is Pleased to Offer a Comprehensive MA and Part D Training Solution
Part D Rejected Claims Review: An Ounce of Prevention is Worth a Pound of Cure